Infectious Enteritis and Proctocolitis and Bacterial Food Poisoning

Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print

Volumn , Issue , 2010, Pages 1843-1887

  Giannella, Ralph A ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930696222     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6189-2.00107-4     Document Type: Chapter

References (372)

1. DuPont HL New insights and directions in traveler’s diarrhea Gastroenterol Clin North Am 35 2006 337-353(Ref 278.)
2. Fasano A Toxins and the gut: Role in human disease Gut 50 2002 iii9-iii14(Ref 5.)
3. Field M Intestinal ion transport and pathophysiology of diarrhea. New Engl J Med 111 2003 931-943(Ref 40.)
4. Giannella RA Treatment of intestinal infections In: Wolfe M Therapy of Digestive Disorders2nd ed 2006 Elsevier Philadelphia 721-731(Ref 349.)
5. Grassi GA., Finlay BB Pathogenesis of enteric Salmonella infections Curr Opin Gastroenterol 24 2008 22-26(Ref 161.)
6. Guerrant RL., Van Gilder T., Steiner TS., et al. Practice guidelines for management of infectious diarrhea Clin Infect Dis 32 2001 331-350(Ref 4.)
7. Kelly CP., LaMont JTAntibiotic-associated diarrhea, pseudomembranous enterocolitis, and Clostridium difficile-associated diarrhea and colitis In: Feldman M., Friedman LS., Brandt LJ Sleisenger and Fordtran’s Gastrointestinal and Liver Disease8th ed 2006 Saunders Philadelphia 2393-2412(Ref 15.)
8. Landzberg BR., Connor BA Persistent diarrhea in the retunring traveler: Think beyond persistent infection Scand J Gastroenterol 40 2005 112-114(Ref 284.)
9. Nataro JP., Kaper JB Diarrheagenic Escherichia coli Clin Microbiol Rev 11 1998 142-201(Ref 29.)
10. Olsen SJ., Aucott JN., Swerdlow DL Food poisoning In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 199-214(Ref 313.)
11. Park SI., Giannella RA Approach to the adult patient with acute diarrhea Gastroenterol Clin North Am 22 1993 483-497(Ref 6.)
12. Sears CL., Acheson DWK Enteric bacterial toxins In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 89-107(Ref 38.)
13. Snyder JD Oral therapy for diarrrhea In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 1241-1249(Ref 338.)
14. Spiller RC Postinfectious irritable bowel syndrome Gastroenterology 124 2003 1662-1671(Ref 293.)
15. Thielman NM., Guerrant RL Acute infectious diarrhea New Engl J Med 350 2004 38-47(Ref 3.)
16. Garthright WE., Archer DL., Kvenberg JE Estimates of incidence and costs of intestinal infectious diseases in the United States Public Health Rep 103 1988 107-105.
17. Mead PS., Slutsker L., Dietz V., et al. Food-related illness and death in the United States Emerg Infect Dis 5 1999 607-625.
18. Thielman NM., Guerrant RL Acute infectious diarrhea New Engl J Med 350 2004 38-47.
19. Guerrant RL., Van Gilder T., Steiner TS., et al. Practice guidelines for management of infectious diarrhea Clin Infect Dis 32 2001 331-350.
20. Fasano A Toxins and the gut: Role in human disease Gut 50 2002 iii9-iii14.
21. Park SI., Giannella RA Approach to the adult patient with acute diarrhea Gastroenterol Clin North Am 22 1993 483-497.
22. Giannella RA., Broitman SA., Zamcheck N The influence of gastric acidity on bacterial and parasitic enteric infections Ann Intern Med 78 1973 271-276.
23. Giannella RA., Broitman SA., Zamcheck N Gastric acid barrier to ingested microorganisms in man: In vivo and in vitro studies Gut 13 1972 251-256.
24. Hornick RB., Music SI., Wenzel R., et al. The Broad Street pump revisited: Response of volunteers to ingested Cholera vibrios Bull N Y Acad Med 47 1971 1181.
25. Gitelson S Gastrectomy, achlorhydria, and cholera Isr J Med Sci 7 1977 663-667.
26. Giannella RA., Broitman SA., Zamcheck N Salmonella enteritis: I. Role of reduced gastric secretion in pathogenesis Am J Dig Dis 11 1971 1000-1006.
27. DuPont HL., Hornick RB., Snyder MJ., et al. Immunity in shigellosis: I. Response of man to attenuated strains of Shigella J Infect Dis 125 1972 5-11.
28. Justus PG., Martin JL., Goldberg DA., et al. Myoelectrical effects of C. difficile: Motility-altering factor distinct from its cytotoxin and enterotoxin in rabbits Gastroenterology 83 1982 836-843.
29. Formal SB., Dammin GJ., LaBrec EH., et al. Experimental shigellosis infection: Characteristics of a fatal infection in guinea pigs J Bacteriol 75 1958 604-610.
30. Kelly CP., LaMont JTAntibiotic-associated diarrhea, pseudomembranous enterocolitis, and Clostridium difficile-associated diarrhea and colitis In: Feldman M., Friedman LS., Brandt LJ Sleisenger and Fordtran’s Gastrointestinal and Liver Disease8th ed 2006 Saunders Philadelphia 2393-2412.
31. Hornick RB., Greisman SE., Woodward TE., et al. Typhoid fever: Pathogenesis and immunologic control N Engl J Med 283 1970 686-691.
32. Bohnhoff M., Miller CP Enhancing susceptibility to Salmonella infection in streptomycin-treated mice J Infect Dis 111 1962 117-127.
33. Shub MD., Pang KY., Swann DA., et al. Age-related changes in chemical composition and physical properties of mucous glycoproteins from rat intestine Biochem J 215 1983 405-411.
34. Davies A An investigation into the serologic properties of dysentery stools Lancet 2 1922 1009-1011.
35. Janoff EN Systemic and mucosal antibody response to enteric pathogens In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 165-182.
36. Goldman AS., Garza C., Nicholas B., et al. Immunological factors in human milk during the first year of lactation J Pediatr 100 1982 563-567.
37. Mata LJ., Urrutia JJ., Fernandez R., et al. Shigellosis in breast-fed Guatemalan Indian neonates Am J Dis Child 117 1969 142-146.
38. Kenny JF., Boesman MI., Michaels RH., et al. Bacterial and viral coproantibodies in breast-fed infants Pediatr 39 1967 202-213.
39. Hanson LA., Anderson B., Carlson B., et al. Defense of mucosal membranes by antibodies, receptor analogues, and non-specific host factors Infection 13 1985 S166-S170.
40. Rothbaum R., McAdams AJ., Giannella RA., Partin JL A clinicopathologic study of enterocyte-adherent E. coli: A cause of protracted diarrhea in infants Gastroenterology 83 1982 441-454.
41. Levine MM., Edelman R Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: Epidemiology and pathogenesis Epidemiol Rev 6 1984 31-51.
42. Moon HW., Whipp SC., Argenzio RA., et al. Attaching and effacing activities of rabbit and human E. coli in pig and rabbit intestine Infect Immun 41 1983 1340-1351.
43. Ulshen MH., Rollo JL Pathogenesis of E. coli gastroenteritis: Another mechanism N Engl J Med 302 1980 99-101.
44. Nataro JP., Kaper JB Diarrheagenic Escherichia coli Clin Microbiol Rev 11 1998 142-201.
45. Donnenberg MS., Kaper JB Enteropathogenic Escherichia coli Infect Immun 60 1992 3953-3961.
46. Jerse AE., Kaper JB The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid Infect Immun 59 1991 4302-4309.
47. Levine MM., Nataro JP., Karch H., et al. The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor J Infect Dis 152 1985 550-559.
48. Donnenberg MS., Tacket CO., James SP., et al. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection J Clin Invest 92 1993 1412-1417.
49. Smith HW., Linggood MA Observations on the pathologic properties of the K88, Hly, and Ent plasmids of E. coli with particular reference to porcine diarrhea J Med Microbiol 4 1971 467-485.
50. Evans DG., Silver RP., Evans DJ Jr., et al. Plasmid-controlled colonization factor associated with virulence in Escherichia coli enterotoxigenic for humans Infect Immun 12 1975 656-667.
51. Moon HW Luminal and mucosal factors of small intestine affecting pathogenic colonization In: Field M., Fordtran JS., Schultz S Secretory Diarrhea 1980 American Physiological Society Bethesda, Md 127-139.
52. Carpenter CC Cholera and other enterotoxin-related diarrheal disorders J Infect Dis 126 1972 551-564.
53. Sears CL., Acheson DWK Enteric bacterial toxins In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 89-107.
54. Giannella RA., Drake KW Effect of purified E. coli heat-stable enterotoxin on intestinal cyclic nucleotide metabolism and fluid secretion Infect Immun 24 1979 19-23.
55. Field M Intestinal ion transport and pathophysiology of diarrhea New Engl J Med 111 2003 931-943.
56. Levine MM E. coli that cause diarrhea J Infect Dis 155 1987 377-389.
57. Cohen MB., Giannella RAEnterotoxigenic E. coli In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 579-594.
58. O’Brien AD., Holmes RK Shiga and Shiga-like toxins Microbiol Rev 51 1987 206-220.
59. Rout WR., Formal SB., Giannella RA Pathophysiology of Shigella diarrhea in the rhesus monkey: Intestinal transport, morphological and bacteriological studies Gastroenterology 68 1975 270-278.
60. LaBrec EH., Schneider H., Magnani IJ., et al. Epithelial cell penetration as an essential step in the pathogenesis of bacillary dysentery J Bacteriol 88 1964 1503-1518.
61. Giannella RA., Formal SB., Dammin GJ., et al. Pathogenesis of salmonellosis: Studies of fluid secretion, mucosal invasion, and morphological reaction in rabbit intestine J Clin Invest 52 1973 441-453.
62. Gill CJ., Lau J., Gorbach SL., Hames DH Diagnostic accuracy of stool assays for inflammatory gastroenteritis Clin Infect Dis 37 2003 365-375.
63. Guerrant RL., Araujo V., Soares E., et al. Measurement of fecal lactoferrin as a marker of fecal leukocytes J Clin Microbiol 30 1992 1238-1242.
64. Koplan JP., Fineberg HV., Ferraro MJB., et al. Value of stool cultures Lancet 2 1980 413-416.
65. Rowland MG., Davies H., Patterson S., et al. Viruses and diarrhea in West Africa and London: A collaborative study Trans R Soc Trop Med Hyg 72 1978 95-98.
66. Watson B., Ellis M., Mandal B., et al. A comparison of the clinico-pathological features with stool pathogens in patients hospitalized with the symptom of diarrhoea Scand J Infect Dis 18 1986 553-559.
67. Jewkes J., Larson HE., Price AB., et al. Aetiology of acute diarrhea in adults Gut 22 1981 388-392.
68. Dryden MS., Gabb RJ., Wright SK Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin Clin Infect Dis 22 1996 1019-1025.
69. Blake PA., Allegra DT., Snyder JD., et al. Cholera: A possible endemic focus in the United States N Engl J Med 310 1980 305-309.
70. Ramamurthy T., Garg S., Sharma R., et al. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India Lancet 341 1993 703-704.
71. Cholera Working Group Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal Lancet 342 1993 387-390.
72. Johnson JA., Salles CA., Panigrahi P., et al. Vibrio cholerae O139 synonym Bengal is closely related to Vibrio cholerae El Tor but has important differences Infect Immun 62 1994 2108-2110.
73. Waldor MK., Mekalanos J Lysogenic conversion by a filamentous phage encoding cholera toxin Science 272 1996 1910-1914.
74. Fasano A., Baudry B., Pumplin DW., et al. Vibrio cholerae produces a second enterotoxin which affects intestinal tight junctions Proc Natl Acad Sci U S A 88 1991 5242-5246.
75. World Health Organization Cholera, 1999 Wkly Epidemiol Rec 75 2000 249.
76. Morris JG., Black RE Cholera and other vibrios in the United States N Engl J Med 312 1985 343-350.
77. Centers for Disease Control and Prevention (CDC) Update: Vibrio cholerae O1-Western hemisphere, 1991-1994, and V. cholerae O139-Asia, 1994 MMWR Morb Mortal Wkly Rep 44 1995 215-219.
78. Ries AA., Vugia DJ., Beingolea L., et al. Cholera in Piura, Peru: A modern urban epidemic J Infect Dis 166 1992 1429-1423.
79. Mujica OJ., Quick RE., Palacios AM., et al. Epidemic cholera in the Amazon: The role of produce in disease risk and prevention J Infect Dis 169 1994 1381-1384.
80. Morris JG., Losonsky GE., Johnson JA., et al. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers J Infect Dis 171 1995 903-908.
81. Basu A., Garg P., Datta S., et al. Vibrio cholerae O139 in Calcutta, 1992-1998: Incidence, antibiograms, and genotypes Emerg Infect Dis 6 2000 139-147.
82. Herrington DA., Hall RH., Losonsky G., et al. Toxin, toxin-coregulated pili and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans J Exp Med 168 1989 1487-1492.
83. World Health Organization Guidelines for cholera control 1993 World Health Organization Geneva.
84. Centers for Disease Control and Prevention (CDC) Update: Cholera-Western Hemisphere, and recommendations for treatment of cholera MMWR Morb Mortal Wkly Rep 40 1991 562-565.
85. Gotuzzo E., Seas C., Echevarria J., et al. Ciprofloxacin for the treatment of cholera: A randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults Clin Infect Dis 20 1995 1485-1490.
86. Khan WA., Bennish ML., Seas C., et al. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139 Lancet 348 1996 296-300.
87. Hamer DH., Gorbach SL Use of the quinolones for the treatment and prophylaxis of bacterial infections In: Andriole VT The Quinolones3rd ed 2000 Academic Press San Diego.
88. Hlady WG., Klontz KC The epidemiology of Vibrio infections in Florida, 1981-1993 J Infect Dis 173 1996 1176-1183.
89. Blake PA., Weaver RE., Hollis DG Diseases of humans (other than cholera) caused by vibrios Annu Rev Microbiol 34 1980 341-367.
90. Hughes JM., Hollis DG., Gangarosa EJ., et al. Vibrio infections in the United States Ann Intern Med 88 1978 602-606.
91. Shapiro RL., Altekruse S., Hutwagner L., et al. and the Vibrio Working Group. The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996 J Infect Dis 178 1998 752-759.
92. Dalsgaard A., Albert MJ., Taylor DN., et al. Characterization of Vibrio cholerae non-O1 serogroups obtained from an outbreak of diarrhea in Lima, Peru J Clin Microbiol 33 1995 2715-2722.
93. Lowry PW., McFarland LM., Peltier BH., et al. Vibrio gastroenteritis in Louisiana: A prospective study among attendees of a scientific congress in New Orleans J Infect Dis 160 1989 978-984.
94. Hoge CW., Watsky D., Peeler RN., et al. Epidemiology and spectrum of vibrio infections in a Chesapeake Bay community J Infect Dis 160 1989 985-993.
95. Calia FM., Johnson DE Bacteremia in suckling rabbits after oral challenge with Vibrio parahaemolyticus Infect Immun 11 1975 1222-1225.
96. Daniels NA., MacKinnon L., Bishop R., et al. Vibrio parahaemolyticus infections in the United States, 1973-1998 J Infect Dis 181 2000 1661-1666.
97. Daniels NA., Ray B., Easton A., et al. Emergence of a new Vibrio parahaemolyticus serotype in raw oysters: A prevention quandary JAMA 284 2000 1541-1545.
98. Klontz KC., Lieb S., Schreiber M., et al. Syndromes of Vibrio vulnificus infections: Clinical and epidemiologic features in Florida cases, 1981-1987 Ann Intern Med 109 1988 318-323.
99. Shandera WX., Johnston JM., Davis BR., et al. Disease from infection with Vibrio mimicus, a newly recognized Vibrio species Ann Intern Med 99 1983 169-161.
100. Hansen W., Freney J., Benyagoub H., et al. Severe human infections caused by Vibrio metschnikovii J Clin Microbiol 31 1993 2529-2530.
101. Janda JM., Abbott SL Unusual food-borne pathogens: Listeria monocytogenes, Aeromonas, Plesiomonas, and Edwardsiella species Clin Lab Med 19 1999 553-582.
102. Namdari H., Bonnone EJ Microbiologic and clinical evidence supporting the role of Aeromonas caviae as a pediatric enteric pathogen J Clin Microbiol 28 1990 837-840.
103. Namdari H., Bottone EJ Cytotoxin and enterotoxin production as factors delineating enteropathogenicity of Aeromonas caviae J Clin Microbiol 28 1990 1796-1798.
104. Holmberg SD., Schell WL., Fanning GR., et al. Aeromonas infections in the United States Ann Intern Med 105 1986 683-689.
105. Gracey M., Burke V., Robinson J Aeromonas-associated gastroenteritis Lancet 2 1982 1304-1306.
106. Holmberg SD., Farmer JJ III Aeromonas hydrophila and Plesiomonas shigelloides as causes of intestinal infections Rev Infect Dis 6 1984 633-639.
107. Jones BL., Wilcox MH Aeromonas infections and their treatment J Antimicrob Chemother 35 1995 453-461.
108. Brenden RA., Miller A., Janda JM Clinical disease spectrum and pathogenic factors associated with Plesiomonas shigelloides infections in humans Rev Infect Dis 10 1988 303-316.
109. Holmberg SD., Wachsmuth K., Hickman-Brenner FW., et al. Plesiomonas enteric infections in the United States Ann Intern Med 105 1986 690-694.
110. Jerse AE., Martin WC., Galen JE., et al. Oligonucleotide probe for detection of the enteropathogenic Escherichia coli (EPEC) adherence factor of localized adherent EPEC J Clin Microbiol 28 1990 2842-2844.
111. Tardelli TA., Rassi V., MacDonald KL., et al. Enteropathogens associated with acute diarrheal disease in urban infants in Sao Paulo, Brazil J Infect Dis 164 1991 331-337.
112. Levine MM., Ferreccio C., Prado V., et al. Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile Am J Epidemiol 138 1993 849-869.
113. Germani Y., Bégaud E., Duval P., et al. Prevalence of enteropathogenic, enteroaggregative, and diffusely adherent Escherichia coli among isolates from children with diarrhea in New Caledonia J Infect Dis 174 1996 1124-1126.
114. Clements JD., Finkelstein RA Immunological cross-reactivity between a heat-labile enterotoxin of Escherichia coli and subunits of Vibrio cholerae enterotoxin Infect Immun 21 1978 1036-1039.
115. Daniels NA., Neimann J., Karpati A., et al. Traveler’s diarrhea at sea: Three outbreaks of waterborne enterotoxigenic Escherichia coli on cruise ships J Infect Dis 181 2000 1491-1495.
116. Merson MH., Sack RB., Islam S., et al. Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: Clinical aspects and a controlled trial of tetracycline J Infect Dis 141 1980 702-711.
117. Evans DJ Jr., Ruiz-Palacios G., Evans DG., et al. Humoral immune response to the heat-labile enterotoxin of Escherichia coli in naturally acquired diarrhea and antitoxin determination by passive immune hemolysis Infect Immun 16 1977 781-788.
118. Mattila L., Peltola H., Siitonen A., et al. Short-term treatment of traveler’s diarrhea with norfloxacin: A double-blind, placebo-controlled study during two seasons Clin Infect Dis 17 1993 779-782.
119. Tulloch EF., Ryan KJ., Formal SB Invasive enteropathic Escherichia coli dysentery: An outbreak in 28 adults Ann Intern Med 79 1973 13-17.
120. Taylor DN., Echeverria P., Sethabutr O., et al. Clinical and microbiologic features of Shigella and enteroinvasive Escherichia coli infections detected by DNA hybridization J Clin Microbiol 26 1988 1362-1366.
121. Riley LW., Remis RS., Helgerson SD., et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype N Engl J Med 308 1983 681-685.
122. Su C., Brandt LJ Escherichia coli O157:H7 infection in humans Ann Intern Med 123 1995 698-714.
123. Griffin PM., Mead PS., Sivapalaswingam SE. coli O157:H7 and other enterohemorrhagic E. coli In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 627-642.
124. Slutsker LA., Ries AA., Green JG., et al. Escherichia coli O157:H7 diarrhea in the United States: Clinical and epidemiological features Ann Intern Med 126 1997 505-513.
125. Martin DL., MacDonald KL., White KE., et al. The epidemiology and clinical aspects of the hemolytic-uremic syndrome in Minnesota N Engl J Med 323 1990 1161-1167.
126. Bell BP., Goldoft M., Griffin PM., et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic-uremic syndrome from hamburgers: The Washington experience JAMA 272 1994 1349-1353.
127. Keene WE., Hedberg K., Herriot DE., et al. A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk J Infect Dis 176 1997 815-818.
128. Besser RE., Lett SM., Weber JT., et al. An outbreak of diarrhea and hemolytic-uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider JAMA 269 1993 2217-2220.
129. Belongia EA., Osterholm MT., Soler JT., et al. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities JAMA 269 1993 883-888.
130. Carter AO., Borczyk AA., Carlson JAK., et al. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home N Engl J Med 317 1987 1496-1500.
131. Karmali MA Infection by verocytotoxin-producing Escherichia coli Clin Microbiol Rev 2 1989 15-38.
132. Law D., Kelly J Use of heme and hemoglobin by Escherichia coli O157 and other Shiga-like toxin-producing E. coli serogroups Infect Immun 63 1995 700-702.
133. Serna A., Boedeker EC Pathogenesis and treatment of Shiga toxin-producing E. coli infections Curr Opin Gastroenterol 24 2008 38-47.
134. Su C., Brandt LJ., Sigal SH., et al. The immunohistological diagnosis of E. coli O157:H7 colitis: Possible association with colonic ischemia Am J Gasteroenterol 93 1998 1055-1059.
135. Milford DV., Taylor CM., Guttridge B., et al. Haemolytic-uraemic syndromes in the British Isles 1985-1988-association with verocytotoxin-producing Escherichia coli: I. Clinical and epidemiological aspects Arch Dis Child 65 1990 716-721.
136. Kleanthous H., Smith HR., Scotland SM., et al. Haemolytic-uraemic syndromes in the British Isles, 1985-1988-association with verocytotoxin-producing Escherichia coli: II. Microbiological aspects Arch Dis Child 65 1990 722-727.
137. Tarr PI., Neill MA., Clausen CR., et al. Escherichia coli O157:H7 and the hemolytic-uremic syndrome: Importance of early cultures in establishing the etiology J Infect Dis 162 1990 553-556.
138. Shah S., Hoffman R., Shillam P., et al. Prolonged fecal shedding of Escherichia coli O157:H7 during an outbreak at a day care center Clin Infect Dis 23 1996 835-836.
139. Karch H., Russman H., Schmidt H., et al. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal disease J Clin Microbiol 33 1995 1602-1605.
140. Zhang X., McDaniel AD., Wolf LE., et al. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice J Infect Dis 181 2000 664-670.
141. Proulx F., Turgeon JP., Delage G., et al. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis J Pediatr 121 1992 299-303.
142. Wong CS., Srdjan J., Habeeb RL., et al. The risk of hemolytic-uremic infections N Engl J Med 342 2000 1930-1936.
143. Safdar N., Said A., Gangnon RE., Maki DG Risk of hemolytic-uremic syndrome after antibiotic treatment of E. coli O157:H7 enteritis JAMA 288 2002 996-1001.
144. Molbak K., Mead PS., Griffin PM Antimicrobial therapy in patients with E. coli O157:H7 infection JAMA 288 2002 1014-1016.
145. Huang DB., Nataro JP., DuPont HL., et al. Enteroaggregative E. coli is a cause of acute diarrheal illness: A meta-analysis Clin infect Dis 43 2006 556-563.
146. Gunzberg ST., Chang BJ., Elliott SJ., et al. Diffuse and enteroaggregative patterns of enteric Escherichia coli isolated from aboriginal children from the Kimberley region of Western Australia J Infect Dis 167 1993 755-758.
147. Wanke CA., Mayer H., Weber R., et al. Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus J Infect Dis 178 1998 185-190.
148. Glandt M., Adachi JA., Mathewson JJ., et al. Enteroaggregative Escherichia coli as a cause of traveler’s diarrhea: Clinical response to ciprofloxacin Clin Infect Dis 29 1999 335-338.
149. Nataro JP., Steiner TSEnteroaggregative and diffusely adherent Escherichia coli In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 613-626.
150. Nataro JP., Yikang D., Cookson S., et al. Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers J Infect Dis 171 1995 465-468.
151. Wanke CA., Gerrior J., Blais V., et al. Successful treatment of diarrheal disease with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus J Infect Dis 178 1998 1369-1372.
152. Keusch GT., Grady GF., Mata LJ., et al. Pathogenesis of shigella diarrhea: I. Enterotoxin production by Shigella dysenteriae 1 J Clin Invest 51 1972 1212-1218.
153. Gots RE., Formal SB., Giannela RA Indomethacin inhibition of Salmonella typhimurium, Shigella flexneri, and cholera-mediated rabbit ileal secretion J Infect Dis 130 1974 280-284.
154. Kinsey MD., Dammin GJ., Formal SB., Giannella RA The role of altered intestinal permeability in the pathogenesis of Salmonella diarrhea in the Rhesus monkey Gastroenterology 71 1976 429-434.
155. Giannella RA., Rout WR., Formal SB., Collins H The role of plasma filtration in the intestinal fluid secretion mediated with infection with Salmonella typhimurium Infect Immun 13 1976 470-474.
156. DuPont HL., Levine MM., Hornick RB., et al. Inoculum size in shigellosis and implications for expected mode of transmission J Infect Dis 159 1989 1126-1128.
157. Gorden J., Small PLC Acid resistance in enteric bacteria Infect Immun 61 1993 364-367.
158. Philipon A., Sansonetti PJ Shigellosis: Innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development Crit Rev Immunol 23 2003 371-401.
159. Acheson DWK., Keusch GTShigella and enteroinvasive Escherichia coli In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 643-668.
160. Keusch GT., Jacewicz M The pathogenesis of shigella diarrhea: VI. Toxin and antitoxin in Shigella flexneri and Shigella sonnei infections in humans J Infect Dis 135 1977 552-556.
161. Barrett-Connor E., Conner JD Extra-intestinal manifestations of shigellosis Am J Gastroenterol 52 1970 234-245.
162. Khan WA., Dhar U., Salam MA., et al. Central nervous system manifestations of childhood shigellosis: Prevalence, risk factors, and outcome Pediatrics 103 1999 E18-E24.
163. Daoud AS., Zaki M., al-Mutari G., et al. Childhood shigellosis: Clinical and bacteriological study J Trop Med Hyg 93 1990 275-279.
164. Koster FT., Boonpuncknavig V., Sujaho S., et al. Renal histopathology in the hemolytic-uremic syndrome following shigellosis Clin Nephrol 21 1984 126-133.
165. Butler T., Islam M., Bardhan PK The leukemoid reaction in shigellosis Am J Dis Child 138 1984 162-165.
166. Tsuchiya N., Husby G., Williams RC., et al. Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid J Clin Invest 86 1990 1193-1203.
167. Nostrant TT., Kumar NB., Appleman HD Histopathology differentiates acute self-limited colitis from ulcerative colitis Gastroenterology 92 1987 318-328.
168. Bennish ML., Salam MA., Khan WA., et al. Treatment of shigellosis: III. Comparison of one-or two-dose ciprofloxacin with standard 5-day therapy-a randomized, blinded trial Ann Intern Med 117 1992 727-734.
169. Khalil K., Khan SR., Mazhar K., et al. Occurrence and susceptibility to antibiotics of Shigella species in stools of hospitalized children with bloody diarrhea in Pakistan Am J Trop Med Hyg 58 1998 800-803.
170. Burkhardt JE., Walterspiel JN., Schaad UB Quinolone arthropathy in animals versus children Clin Infect Dis 25 1997 1196-1204.
171. Gendrel D., Moreno JL., Nduwimana M., et al. One-dose treatment of pefloxacin for infection due to multidrug-resistant Shigella dysenteriae type 1 in Burundi Clin Infect Dis 24 1997 83.
172. Salam MA., Dhar U., Khan AK., et al. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis Lancet 352 1998 522-527.
173. Murphy GS., Bodhidatta L., Echeverria P., et al. Ciprofloxacin and loperamide in the treatment of bacillary dysentery Ann Intern Med 118 1993 582-586.
174. Haltalin KC., Nelson JD., Hinton LV., et al. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis J Pediatr 2 1968 708-720.
175. Nelson JD., Haltalin KC Amoxicillin less effective than ampicillin against Shigella in vitro and in vivo: Relationship of efficacy to activity in serum J Infect Dis 1974 S222-S229.
176. Wang LH., Fang XC., Pan GZ Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis Gut 53 2004 1096-1101.
177. Le Minor L., Popoff MY Designation of Salmonella enterica sp nov, non rev, as the type and only species of the genus Salmonella Int J Sys Bacteriol 37 1987 465-470.
178. Grassi GA., Finlay BB Pathogenesis of enteric Salmonella infections Curr Opin Gastroenterol 24 2008 22-26.
179. Zhang S., Kingsley RA., Santos RL., et al. Molecular pathogenesis of Salmonella enterica serotype Tyhimurium-induced diarrhea Infec Immun 71 2003 1-12.
180. Fields PI., Groisman EA., Heffron F A Salmonella locus that controls resistance to microbial proteins from phagocytic cells Science 243 1989 1059-1062.
181. McCormick BA., Miller SI., Carnes D., et al. Transepithelial signaling to neutrophils by salmonellae: A novel virulence mechanism for gastroenteritis Infect Immun 63 1995 2302-2309.
182. Wallis TS., Starkey WG., Stephen J., et al. Enterotoxin production by Salmonella typhimurium strains of different virulence J Med Microbiol 21 1986 19-23.
183. Chopra AK., Huang JH., Xu XJ., et al. Role of Salmonella enterotoxin in overall virulence of the organism Microb Pathogen 27 1999 155-171.
184. Pavia AT., Shipman LD., Wells JG., et al. Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella J Infect Dis 161 1990 255-260.
185. Kaye D., Gill FA., Hook EW Factors influencing host resistance to Salmonella infections: The effects of hemolysis and erythrophagocytosis Am J Med Sci 254 1967 205-215.
186. Hand WL., King NL Serum opsonization of Salmonella in sickle cell anemia Am J Med 64 1977 388-395.
187. Han T., Sokal JE., Neter E Salmonellosis in disseminated malignant diseases N Engl J Med 276 1967 1045-1052.
188. Glaser JB., Morton-Kute L., Berger SR Recurrent Salmonella typhimurium bacteremia associated with the acquired immune deficiency syndrome Ann Intern Med 102 1985 189-193.
189. Rocha H., Brazil S., Kirk JW., et al. Prolonged Salmonella bacteremia in patients with Schistosoma mansoni infection Arch Intern Med 128 1971 254-257.
190. Lindeman RJ., Weinstein L., Levitan R., et al. Ulcerative colitis and intestinal salmonellosis Am J Med Sci 254 1967 855-861.
191. Rubin HR., Weinstein L Salmonellosis: Microbiologic, pathologic, and clinical features 1977 Stratton Intercontinental New York.
192. Gray JI., Trueman AM Severe Salmonella gastroenteritis associated with hypochlorhydria Scot Med J 16 1971 255-258.
193. Musher DN., Rubenstein AD Permanent carriers of nontyphosa salmonellae Arch Intern Med 132 1973 869-872.
194. Deppisch LM., Grans CA Salmonellosis: A cause of toxic megacolon J Clin Gastroenterol 12 1990 605-607.
195. Neill MA., Opal SM., Heelan J., et al. Failure of ciprofloxacin in convalescent fecal excretion after acute salmonellosis: Experience during an outbreak in health care workers Ann Intern Med 114 1991 195-199.
196. Sirinavin S, Garner P. Antibiotics for treating Salmonella gut infections. Cochrane Database Syst Rev 2000;(2):CD001167.
197. Stanley PJ., Flegg PJ., Mandal BK., et al. Open study of ciprofloxacin in enteric fever J Antimicrob Chemother 23 1989 789-791.
198. Cherubin CE., Kowalski J Nontyphoidal Salmonella carrier state treated with norfloxacin Ann Intern Med 85 1990 100-101.
199. Piddock LJV., Whale K., Wise R Quinolone resistance in Salmonella: Clinical experience Lancet 1 1990 1459.
200. Malorny B., Schroeter A., Helmuth R Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany Antimicrob Agents Chemother 43 1999 2278-2282.
201. Fey PD., Safranek TJ., Rupp ME., et al. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle N Engl J Med 342 2000 1242-1249.
202. Tarr PE., Kuppens L., Jones TC., et al. Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: Potential use in an epidemic in Tajikistan Am J Trop Med Hyg 61 1999 163-170.
203. Mermin JH., Townes JM., Gerber M., et al. Typhoid fever in the United States, 1985-1994: Changing risks of international travel and antimicrobial resistance Arch Intern Med 158 1998 633-638.
204. Stuart BM., Pullen RL Typhoid: Clinical analysis of 360 cases Arch Intern Med 78 1946 629-639.
205. Woodward TE., Smadel JE Management of typhoid fever and its complications Ann Intern Med 60 1964 144-157.
206. Butler T., Knight J., Nath SK., et al. Typhoid fever complicated by intestinal perforation: A persisting fatal disease requiring surgical management Rev Infect Dis 7 1985 244-256.
207. Kaye D., Merselis JG., Connolly CS., et al. Treatment of chronic carriers of Salmonella typhosa with ampicillin Ann N Y Acad Sci 145 1967 429-435.
208. Gilman RH., Terminel M., Levine MM., et al. Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever Lancet 1 1975 1211-1213.
209. Robertson RP., Wahab MFA., Raasch FO Evaluation of chloramphenicol and ampicillin in Salmonella enteric fever N Engl J Med 278 1968 171-176.
210. Chitnis V., Chitnis D., Verma S., et al. Multidrug-resistant Salmonella typhi in India Lancet 354 1999 514-515.
211. Wain J., Hoa NTT., Chinh NT., et al. Quinolone-resistant Salmonella typhi in Vietnam: Molecular basis of resistance and clinical response to treatment Clin Infect Dis 25 1997 1404-1410.
212. Soe GB., Overturf GD Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other new cephalosporins Rev Infect Dis 9 1987 719-736.
213. Acharya G., Butler T., Ho M., et al. Treatment of typhoid fever: Randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol Am J Trop Med Hyg 52 1995 162-165.
214. Cao XT., Kneen R., Anh NT., et al. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children Pediatr Infect Dis J 18 1999 245-248.
215. Hoffman SL., Punjabi NH., Kumala S., et al. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone N Engl J Med 310 1984 82-88.
216. Bitar R., Tarpley J Intestinal perforation in typhoid fever: An historical and state-of-the-art review Rev Infect Dis 7 1985 257-271.
217. Mock CN., Amaral J., Visser LE Improvement in survival from typhoid ileal perforation: Results of 221 operative cases Ann Surg 215 1992 244-249.
218. Rodriguez-Noriega E., Andrade-Villanueva J., Amaya-Tapia G Quinolones in the treatment of Salmonella carriers Rev Infect Dis 11 1989 S1179-S1187.
219. Wahdan MH., Serie C., Cerisier Y., et al. A controlled field trial of live Salmonella typhi Ty 21a oral vaccine against typhoid: Three-year results J Infect Dis 145 1982 292-295.
220. Levine MM., Ferreccio C., Black RE., et al. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation Lancet 1 1987 1049-1051.
221. Hirschel B., Wurthrich R., Somaini B., et al. Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid: Three-year results Eur J Clin Microbiol 4 1985 295-298.
222. Altekruse SF., Stern NJ., Fields PI., et al. Campylobacter jejuni: An emerging foodborne pathogen Emerg Infect Dis 5 1999 28-35.
223. Deming MS., Tauxe RV., Blake PA., et al. Campylobacter enteritis at a university: Transmission from eating chicken and from cats Am J Epidemiol 126 1987 526-534.
224. Mishu Allos B., Blaser MJ Campylobacter jejuni and the expanding spectrum of related infections Clin Infect Dis 20 1995 1092-1102.
225. Kapperud G., Lassen J., Ostroff SM., et al. Clinical features of sporadic Campylobacter infections in Norway Scand J Infect Dis 24 1992 741-749.
226. Rees JH., Soudain SE., Gregson NA., et al. Campylobacter jejuni infection and Guillain-Barré syndrome N Engl J Med 333 1995 1374-1379.
227. Lecuit M., Abachin W., Martin A., et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni N Engl J Med 350 2004 239-248.
228. Levine MM Antimicrobial therapy for infectious diarrhea Rev Infect Dis 8 1986 S207-S216.
229. Pichler HET., Diridl G., Stickler K., et al. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea Am J Med 82 S4A 1987 329-335.
230. Segreti J., Gootz TD., Goodman LJ., et al. High-level quinolone resistance in clinical isolates of Campylobacter jejuni J Infect Dis 165 1992 667-670.
231. Wretlind B., Stromberg A., Ostlund L., et al. Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin Scand J Infect Dis 24 1992 685-686.
232. Kuschner RA., Trofa AF., Thomas RJ., et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent Clin Infect Dis 21 1995 536-541.
233. Smith KE., Besser JM., Hedberg CW., et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998 N Engl J Med 340 1999 1525-1532.
234. Talsma E., Goettsch WG., Nieste HLJ., et al. Resistance in Campylobacter species: Increased resistance to fluoroquinolones and seasonal variation Clin Infect Dis 29 1999 845-848.
235. Naktin J., Beavis KG Yersinia enterocolitica and Yersinia pseudotuberculosis Clin Lab Med 19 1999 523-536.
236. Isberg RR., Leong JM Cultured mammalian cells attach to the invasion protein of Yersinia pseudotuberculosis Proc Natl Acad Sci U S A 85 1988 6682-6686.
237. Ackers M-L., Schoenfeld S., Markman J., et al. An outbreak of Yersinia enterocolitica O:8 infections associated with pasteurized milk J Infect Dis 181 2000 1834-1817.
238. Simmonds SD., Noble MA., Freeman HJ Gastrointestinal features of culture-positive Yersinia enterocolitica infection Gastroenterology 92 1987 112-117.
239. Ostroff SM., Kapperud G., Lassen J., et al. Clinical features of sporadic Yersinia enterocolitica infections in Norway J Infect Dis 166 1992 812-817.
240. Vantrappen G., Pouette E., Geboes K Yersinia enteritis and enterocolitis: Gastroenterological aspects Gastroenterology 72 1977 220-217.
241. Puylaert JBCM., Cermeijden RJ., Van Der Werf SDJ., et al. Incidence and sonographic diagnosis of bacterial ileocaecitis masquerading as appendicitis Lancet 2 1989 84-88.
242. Granfor K., Jalkanan S., Von Essen R., et al. Yersinia antigens in synovial fluid cells from patients with reactive arthritis N Engl J Med 320 1989 216-221.
243. DeKoning J., Heesemann J., Hoogkamp-Korstanje JAA., et al. Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: Correlation with specific serum IgA antibodies J Infect Dis 159 1989 109-112.
244. Bottone EJ., Sheehan DJ Yersinia enterocolitica: Guidelines for serologic diagnosis of human infections Rev Infect Dis 5 1982 898-906.
245. Pai CH., Gillis F., Tuomanen E., et al. Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis J Pediatr 104 1984 308-311.
246. Blacklow NR., Greenberg HB Viral gastroenteritis N Engl J Med 325 1991 252-264.
247. Waters V., Ford-Jones EL., Petric M., et al. Etiology of community-acquired pediatric viral diarrhea: A prospective longitudinal study in hospitals, emergency departments, pediatric practices, and child care centers during the winter rotavirus outbreak, 1997 to 1998 Pediatr Infect Dis J 19 2000 843-848.
248. Davidson GP., Barnes GL Structural and functional abnormalities of the small intestine in infants and young children with rotavirus enteritis Acta Paediatr Scand 68 1979 181-186.
249. Lundgren O., Peregrin AT., Persson K., et al. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea Science 287 2000 491-495.
250. Morris AP., Estes MK Microbes and microbial toxins: Paradigm for microbial-mucosal interactions: VIII. Pathological consequences of rotavirus infection and its enterotoxin Am J Physiol 281 2001 G303-G310.
251. Rodriguez WJ., Kim HW., Brandt CD., et al. Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: Clinical and epidemiologic observations Pediatr Infect Dis J 6 1987 170-176.
252. Zheng BJ., Lo SKF., Tam JSL., et al. Prospective study of community-acquired rotavirus infection J Clin Microbiol 27 1989 2083-2090.
253. Richardson S., Grimwood K., Gorrell R., et al. Extended excretion of rotavirus after severe diarrhoea in young children Lancet 351 1998 1844-1848.
254. Wilde J., Yolken R., Willoughby R., et al. Improved detection of rotavirus shedding by polymerase chain reaction Lancet 337 1991 323-326.
255. Gouvea V., Allen JR., Glass RI., et al. Detection of group B and C rotaviruses by polymerase chain reaction J Clin Microbiol 29 1991 519-523.
256. Matson DO., O’Ryan ML., Herrera I., et al. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections J Infect Dis 167 1993 577-583.
257. Brussow H., Wechau H., Lerner L., et al. Seroconversion patterns to four human rotavirus serotypes in hospitalized infants with acute rotavirus gastroenteritis J Infect Dis 158 1988 588-595.
258. Ward RL., Bernstein D I, for the U.S. Rotavirus Vaccine Efficacy Group. Protection against rotavirus disease after natural rotavirus infection J Infect Dis 169 1994 900-904.
259. Glass RI., Stoll BJ., Wyatt RG., et al. Observations questioning a protective role for breast-feeding in severe rotavirus diarrhea Acta Paediatr Scand 75 1986 713-718.
260. Yolken RH., Peterson JA., Vonderfecht SL., et al. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis J Clin Invest 90 1992 1984-1991.
261. Newburg DS., Peterson JA., Ruiz-Palacios GM., et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection Lancet 351 1998 1160-1164.
262. Santosham M., Burns B., Nadkarni V., et al. Oral rehydration therapy for acute diarrhea in ambulatory children in the United States: A double-blind comparison of four different solutions Pediatrics 76 1985 159-156.
263. Centers for Disease Control and Prevention (CDC) Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children MMWR Morb Mortal Wkly Rep 48 Suppl RR2 1999 1-20.
264. Sarker SA., Casswall TH., Mahalanabis D., et al. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum Pediatr Infect Dis J 17 1998 1149-1154.
265. Green KY., Ando T., Balayan MS., et al. Taxonomy of the caliciviruses J Infect Dis 181 Suppl. 2 2000 S322-S330.
266. Matson DO., Estes MK., Glass RI., et al. The occurrence of calicivirus-associated diarrhea in children attending day care centers J Infect Dis 159 1989 71-78.
267. O’Ryan ML., Mamani N., Gaggero A., et al. Human caliciviruses are a significant pathogen of acute sporadic diarrhea in children of Santiago, Chile J Infect Dis 182 2000 1519-1522.
268. Jiang X., Graham DY., Wang K., et al. Norwalk virus genome cloning and characterization Science 250 1990 1580-1582.
269. Morse DL., Guzewich JJ., Hanrahan JP., et al. Widespread outbreaks of clam-and oyster-associated gastroenteritis: Role of Norwalk virus N Engl J Med 314 1986 678-681.
270. Fankhauser RL., Noel JS., Monroe SS., et al. Molecular epidemiology of Norwalk-like viruses in outbreaks of gastroenteritis in the United States J Infect Dis 178 1998 1571-1578.
271. Kukkula M., Maunula L., Silvennoinen E., et al. Outbreak of viral gastroenteritis due to drinking water contaminated by Norwalk-like viruses J Infect Dis 180 1999 1771-1776.
272. Kuritsky JN., Osterhold MT., Greenberg HB., et al. Norwalk gastroenteritis: A community outbreak associated with bakery product consumption Ann Intern Med 100 1984 519-521.
273. Moe CL., Gentsch J., Grohmann G., et al. Application of PCR to detect Norwalk virus in fecal specimens from outbreaks of gastroenteritis J Clin Microbiol 32 1994 642-648.
274. Herrmann JE., Blacklow NR., Matsui SM., et al. Monoclonal antibodies for detection of Norwalk virus antigen in stools J Clin Microbiol 33 1995 2511-2513.
275. Johnson PC., Mathewson JJ., DuPont HL., et al. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in U.S. adults J Infect Dis 161 1990 18-21.
276. Kotloff KL., Losonsky GA., Morris JG Jr., et al. Enteric adeno-virus infection and childhood diarrhea: An epidemiologic study in three clinical settings Pediatrics 84 1989 219-221.
277. Van R., Wun CC., O’Ryan ML., et al. Outbreaks of human enteric adenovirus types 40 and 41 in Houston day care centers J Pediatr 120 1992 516-521.
278. Lew JF., Moe CL., Monroe SS., et al. Astrovirus and adenovirus associated with diarrhea in children in day care settings J Infect Dis 164 1991 673-678.
279. Kurtz JB., Lee TW Astroviruses: Human and animal Ciba Found Symp 128 1987 92-107.
280. Herrmann JE., Taylor DN., Echeverria P., et al. Astroviruses as a cause of gastroenteritis in children N Engl J Med 324 1991 1757-1760.
281. Mitchell DK., Monroe SS., Jiang X., et al. Virologic features of an astrovirus diarrhea outbreak in a day care center revealed by reverse transcriptase polymerase chain reaction J Infect Dis 172 1995 1437-1444.
282. Naficy AB., Rao MR., Holmes JL., et al. Astrovirus diarrhea in Egyptian children J Infect Dis 182 2000 685-690.
283. Moe CL., Allen JR., Monroe SS., et al. Detection of astrovirus in pediatric stool samples by immunoassay and RNA probe J Clin Microbiol 29 1991 2390-2395.
284. Koopmans M., Horzinek MC Toroviruses of animals and humans: A review Adv Virus Res 43 1994 233-273.
285. Koopmans MPG., Goosen ESM., Lima AM., et al. Association of torovirus with acute and persistent diarrhea in children Pediatr Infect Dis J 16 1997 504-507.
286. Jamieson FB., Wang EEL., Bain C., et al. Human torovirus: A new nosocomial gastrointestinal pathogen J Infect Dis 178 1998 1263-1269.
287. McFarland LV., Mulligan ME., Kwok RYY., et al. Nosocomial acquisition of C. difficile infection N Engl J Med 320 1989 204-210.
288. Siegel D., Edelstein P., Nachamkin I Inappropriate testing for diarrheal disease in the hospital JAMA 263 1990 979-982.
289. Prien-Larsen J., Stjernquist M Malaria in pregnancy Acta Obstet Gynecol Scand 72 1993 496-497.
290. Kerrigan K Fulminant amoebic colitis in pregnancy Trop Doctor 21 1991 46-47.
291. Hill D Giardia lamblia In: Mandel G., Bennett J., Dolin R Principles and Practice of Infectious Disease 1995 Churchill Livingstone New York 2487-2493.
292. Simor A., Ferro S Campylobacter jejuni infection occurring during pregnancy Eur J Clin Microbiol Infect Dis 9 1990 142-144.
293. Armor S Periparturitional shigellosis Neb Med J 75 1990 239-241.
294. Rebarber A., Star Hampton B., Lewis V., Bender S Shigellosis complicating preterm premature rupture of membranes resulting in congenital infection and preterm delivery Obstet Gynecol 100 2002 1063-1065.
295. DuPont HL New insights and directions in traveler’s diarrhea Gastroenterol Clin North Am 35 2006 337-353.
296. Steffen R., Collard F., Tornieporth N., et al. Epidemiology, etiology, and impact of traveler’s diarrhea in Jamaica JAMA 281 1999 811-817.
297. Steffen R Epidemiologic studies of travelers’ diarrhea, severe gastrointestinal infections, and cholera Rev Infect Dis 8 Suppl 2 1986 S122-S130.
298. Shlim DR., Hoge CW., Rajah R., et al. Persistent high risk of diarrhea among foreigners in Nepal during the first 2 years of residence Clin Infect Dis 29 1999 613-616.
299. MacDonald K., Cohen M Epidemiology of traveler’s diarrhea: Current perspectives Rev Infect Dis 8 Suppl 2 1986 S117-S121.
300. Black RE Epidemiology of travelers’ diarrhea and relative importance of various pathogens Rev Infect Dis 12 Suppl 1 1990 S73-S79.
301. Landzberg BR., Connor BA Persistent diarrhea in the returning traveler: Think beyond persistent infection Scand J Gastroenterol 40 2005 112-114.
302. Johnson PC., Ericsson CD., DuPont HL., et al. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers diarrhea JAMA 255 1986 757-760.
303. Ericsson CD., DuPont HL., Mathewson JJ., et al. Treatment of travelers’ diarrhea with sulfamethoxazole and trimethoprim and loperamide JAMA 263 1990 257-261.
304. Ericsson CD., Johnson PC., DuPont HL., et al. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers’ diarrhea Ann Intern Med 106 1987 216-222.
305. Salam I., Katelaris P., Leigh-Smith S., et al. Randomised trial of single-dose ciprofloxacin for travellers’ diarrhoea Lancet 344 1994 1537-1539.
306. DuPont HL., Jiang Z-D., Ericsson CD., et al. Rifaximin versus ciprofloxacin for the treatment of traveler’s diarrhea: A randomized, double-blind clinical trial Clin Infect Dis 33 2001 1807-1815.
307. Steffen R., Sack DA., Riopel L., et al. Therapy of traveler’s diarrhea with rifaximin on various continents Am J Gastroenterol 98 2003 1073-1078.
308. Adachi JA., Ostrosky-Zeichner L., DuPont HL., et al. Empirical antimicrobial therapy for traveler’s diarrhea Clin Infect Dis 31 2000 1079-1083.
309. Chak A., Banwell JG Traveler’s diarrhea Gastroenterol Clin North Am 22 1993 549-561.
310. Spiller RC Postinfectious irritable bowel syndrome Gastroenterology 124 2003 1662-1671.
311. Neal KR., Barker L., Spiller RC Prognosis in post-infectious irritable bowel syndrome: A 6-year follow up study Gut 51 2002 410-413.
312. Lew JF., Glass RI., Gangarosa RE., et al. Diarrheal deaths in the United States, 1979 through 1987: A special problem for the elderly JAMA 265 1991 3280-3284.
313. Trinh C., Prabhakar K. Diarrheal diseases in the elderly Clin Geriatr Med 23 2007 833-856.
314. Garibaldi RA., Brodine S., Matsumiya S., et al. Infections among patients in nursing homes N Engl J Med 305 1981 731-735.
315. Bartlett JG., Gerding DN Clinical recognition and diagnosis of Clostridium difficile infection Clin Infect Dis 46 Suppl 1 2008 S12-S18.
316. DuPont HL., Garey K., Caeiro JP., et al. New advances in Clostridium difficile infection: Changing epidemiology, diagnosis, treatment and control Curr Opin Infect Dis 21 2008 500-507.
317. Swerdlow DL., Woodruff BA., Brady RC., et al. A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody diarrhea and death Ann Intern Med 117 1992 812-819.
318. Borriello SP., Barclay FE., Welch AR., et al. Epidemiology of diarrhoea caused by enterotoxigenic Clostridium perfringens J Med Microbiol 20 1985 363-372.
319. Gordon SM., Oshiro LS., Jarvis WR., et al. Foodborne Snow Mountain agent gastroenteritis with secondary person-to-person spread in a retirement community Am J Epidemiol 131 1990 702-710.
320. Neill MA., Rice SK., Ahmad NV., et al. Cryptosporidiosis: An unrecognized cause of diarrhea in elderly hospitalized patients Clin Infect Dis 22 1996 168-170.
321. Horvath KD., Whelan RL Intestinal tuberculosis: Return of an old disease Am J Gastroenterol 93 1998 692-696.
322. Marshall JB Tuberculosis of the gastrointestinal tract and peritoneum Am J Gastroenterol 88 1993 989-999.
323. Shah S., Thomas V., Mathan M., et al. Colonoscopic study of 50 patients with colonic tuberculosis Gut 33 1992 347-351.
324. McGee GS., Williams LF., Potts J., et al. Gastrointestinal tuberculosis: Resurgence of an old pathogen Am Surg 55 1989 16-20.
325. Kim KM., Lee A., Choi YK., et al. Intestinal tuberculosis: Clinicopathologic analysis and diagnosis by endoscopic biopsy Am J Gastroenterol 93 1998 606-609.
326. Balthazar EJ., Gordon R., Hulnick D Ileocecal tuberculosis: CT and radiologic evaluation Am J Roentgenol 154 1990 499-503.
327. Park SJ., Han JK., Kim JS., et al. Tuberculous colitis: Radiologic-colonoscopic correlation Am J Roentgenol 175 2000 121-128.
328. Bentley G., Webster JHH Gastrointestinal tuberculosis: A 10-year review Br J Surg 54 1967 90-96.
329. Chen W-S., Su W-J., Wang H-S., et al. Large bowel tuberculosis and possible influencing factors for surgical prognosis: 30 years’ experience World J Surg 21 1997 500-504.
330. Olsen SJ., Aucott JN., Swerdlow DL Food poisoning In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 199-214.
331. Olson SJ., MacKinnon LC., Goulding JS., et al. Surveillance for foodborne-disease outbreaks-United States, 1993-1997 MMWR Morb Mortal Wkly Rep 49 Suppl. SS-1 2000 1-10.
332. Crane JK Preformed bacterial toxins Clin Lab Med 19 1999 583-599.
333. Centers for Disease Control and Prevention (CDC) Vibrio vulnificus infections associated with raw oyster consumption, Florida 1981-1992 MMWR 42 1993 405-407.
334. Johnston IM., Becker SI., McFarland LM Vibrio vulnificus: Man and the sea JAMA 253 1985 2850-2853.
335. Sullivan R., Asano T Effects of staphylococcal enterotoxin B on intestinal transport in the rat Am J Physiol 222 1971 1793-1797.
336. Duncan CL., Strong DH Clostridium perfringens type A food poisoning: I. Response of the rabbit ileum as an indication of enteropathogenicity of strains of Clostridium perfringens in monkeys Infect Immun 3 1971 167-170.
337. McDonel JL., Duncan CL Regional localization of activity of Clostridium perfringens type A enterotoxin in the rabbit ileum, jejunum, and duodenum J Infect Dis 136 1977 661-666.
338. Murrell TGC., Egerton JR., Rampling A., et al. The ecology and epidemiology of the pigbel syndrome in man in New Guinea J Hyg Camb 64 1966 375-396.
339. Petrillo TM., Beck-Sagué CM., Songer JG., et al. Enteritis necroticans (pigbel) in a diabetic child N Engl J Med 342 2000 1250-1253.
340. Schlech WF III Foodborne listeriosis Clin Infect Dis 31 2000 770-775.
341. Schuhat A., Deaver KA., Wenger JD., et al. Role of foods in sporadic listeriosis: I. Case-control study of dietary risk factors JAMA 267 1992 2041-2045.
342. Pinner RW., Schuchat A., Swaminathan B., et al. Role of foods in sporadic listeriosis: II. Microbiologic and epidemiologic investigation JAMA 267 1992 2046-2050.
343. Aureli P., Fiorucci GC., Caroli D., et al. An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes N Engl J Med 342 2000 1236-1241.
344. Terranova W., Blake PA Bacillus cereus food poisoning N Engl J Med 298 1978 143-144.
345. Gilbert RJ., Parry JM Serotypes of Bacillus cereus from outbreaks of food poisoning and from routine foods J Hyg Camb 78 1977 69-74.
346. Melling J., Capel BJ., Turnbull PCB., et al. Identification of a novel enterotoxigenic activity associated with Bacillus cereus J Clin Pathol 29 1976 938-940.
347. Mortimer PR., McCann G Food poisoning episodes associated with Bacillus cereus in fried rice Lancet 1 1974 1043-1045.
348. Shapiro RL., Hatheway C., Swerdlow DL Botulism in the United States: A clinical and epidemiologic review Ann Intern Med 129 1998 221-228.
349. Tacket CO., Shandera WX., Mann JM., et al. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism Am J Med 76 1984 794-798.
350. Dixon TC., Meselson M., Guillemin J., Hanna PC Anthrax N Engl J Med 341 1999 815-826.
351. Human ingestion of Bacillus anthracis-contaminated meat-Minnesota, August 2000 MMWR Mort Morb Wkly Rep 49 2000 813-818.
352. Morris JG Natural toxins associated with fish and shellfish In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 215-221.
353. Barbier HMJ., Diaz JH Prevention and treatment of toxic seafood-borne diseases in travelers J Travel Med 10 2003 29-37.
354. Vernoux JP., Lewis RJ Isolation and characterization of Caribbean ciguatoxins from the horse-eye Jack (Caranx latus) Toxicon 35 1997 889-900.
355. Snyder JD Oral therapy for diarrhea In: Blaser M., Smith P., Ravdin J Infections of the Gastrointestinal Tract2nd ed 2002 Lippincott Williams & Wilkins Philadelphia 1241-1249.
356. Santosham M., Daum AS., Dillman L., et al. Oral rehydration therapy of infantile diarrhea: A controlled study of well-nourished children hospitalized in the United States and Panama N Engl J Med 306 1982 1071-1076.
357. Guarino A., Albano F., Guandalini S., et al. Oral rehydration: Toward a real solution J Pediatr Gastroenterol Nutr 33 2001 S2-12.
358. Thillainayagam AV., Hunt JB., Farthing MJG Efficacy of oral rehydration therapy: Is low osmolality the key? Gastroenterology 114 1998 197-210.
359. Santosham M., Greenough WB Oral rehydration therapy: A global perspective J Pediatr 118 1991 S44-S51.
360. Cutting WA., Belton NR., Gray JA., et al. Safety and efficacy of three oral rehydration solutions for children with diarrhoea (Edinburgh 1984-1985) Acta Paediatr Scand 78 1989 253-258.
361. International Study Group on Reduced-Osmolarity ORS Solutions Multicentre evaluation of reduced-osmolarity oral rehydration salts solution Lancet 345 1995 282-285.
362. Gore SM., Fontaine O., Pierce NF Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: Meta-analysis of 13 clinical trials BMJ 304 1992 287-291.
363. Ramakrishna BS., Venkataraman S., Srinivasan P., et al. Amylase-resistant starch plus oral rehydration solutions for cholera N Engl J Med 342 2000 308-313.
364. Savarino SJ., Levine MM Specific and nonspecific treatment of diarrhea In: Gorbach SL., Bartlett JG., Blacklow NR Infectious Diarrhea 1992 WB Saunders Philadelphia 638-648.
365. Goodman LJ., Trenholme GM., Kaplan RL., et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults Arch Intern Med 150 1990 541-546.
366. Giannella RA Treatment of intestinal infections In: Wolfe M Therapy of Digestive Disorders2nd ed 2006 Elsevier Philadelphia 721-731.
367. Wistrom J., Norrby SR Fluoroquinolones and bacterial enteritis: When and for whom? J Antimicrob Chemother 36 1995 23-39.
368. Islam MR Single-dose tetracycline in cholera Gut 28 1987 1029-1032.
369. Oldfield EC III., Bourgeois AL., Omar AK., et al. Empirical treatment of Shigella dysentery with trimethoprim: Five-day course versus single dose Am J Trop Med Hyg 37 1986 616-623.
370. Butler T., Lolekha S., Rasidi C., et al. Treatment of acute bacterial diarrhea: A multicenter international trial comparing placebo with fleroxacin given as a single dose or once daily for 3 days Am J Med 94 Suppl. 3A 1993 187S-194S.
371. DuPont HL., Hornick RB Adverse effect of Lomotil therapy in shigellosis JAMA 226 1990 1525-1528.
372. DuPont HL., Sullivan P., Pickering LK., et al. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university Gastroenterology 73 1977 715-718.